Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetologia

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s001250100003PMID 11719830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired glucose tolerance: the irrepressible alpha-cell?

  2000cited by this paper
• Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women

  2000cited by this paper
• Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.

  2000cited by this paper
• Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

  2000cited by this paper
• Advances in non-peptide glucagon receptor antagonists.

  1999cited by this paper
• Impact of lack of suppression of glucagon on glucose tolerance in humans.

  1999cited by this paper
• The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

  1998cited by this paper
• Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance

  1996cited by this paper
• Evidence for a Major Role for Glucagon in Regulation of Plasma Glucose in Conscious, Nondiabetic, and Alloxan-Induced Diabetic Rabbits

  1996cited by this paper
• Pathogenesis and Treatment of Type 2 (Noninsulin-Dependent) Diabetes Mellitus (NIDDM)

  1996cited by this paper
• Role of glucagon in maintenance of euglycemia in fed and fasted rats.

  1995cited by this paper
• Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle‐aged women

  1995cited by this paper
• Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion

  1995cited by this paper
• Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

  1995cited by this paper
• Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats

  1994cited by this paper
• Molecular and functional characterization of insulin receptors present on hamster glucagonoma cells.

  1994cited by this paper
• Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

  1993cited by this paper
• Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

  1992cited by this paper
• The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM

  1988cited by this paper
• Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics

  1987cited by this paper
• Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.

  1987cited by this paper
• Pancreatic hormone receptors on islet cells.

  1985cited by this paper
• Abnormal Glucose Modulation of Islet A- and B-Cell Responses to Arginine in Non-insulin-dependent Diabetes Mellitus

  1985cited by this paper
• Diabetes mellitus. Report of a WHO Study Group.

  1985cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

  1970cited by this paper
• Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

  1967cited by this paper

• Blockade of glucagon receptor induces α-cell hypersecretion by hyperaminoacidemia in mice

  2025cites this paper
• Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.

  2025cites this paper
• Prediabetes remission to reduce the global burden of type 2 diabetes.

  2025cites this paper
• Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation

  2025influential citation
• Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes

  2024cites this paper
• Glucagon kinetics assessed by mathematical modelling during oral glucose administration in people spanning from normal glucose tolerance to type 2 diabetes

  2024cites this paper
• Inadequate Glucagon Suppression During OGTT in prediabetes: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance

  2023cites this paper
• Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans.

  2023cites this paper
• Where to for precision treatment of HNF1A-MODY?

  2022cites this paper
• Glucagon transiently stimulates mTORC1 by activation of an EPAC/Rap1 signaling axis.

  2021cites this paper
• The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes

  2021cites this paper
• Hyperglucagonemia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - A study from South India.

  2021cites this paper
• Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test

  2021cites this paper
• A Narrative Review of Human Clinical Trials on the Impact of Phenolic-Rich Plant Extracts on Prediabetes and Its Subgroups

  2021cites this paper
• On Meal Effects and DPP-4 Inhibition Islet- and Incretin Hormones in Health and Type 2 Diabetes

  2020cites this paper
• Fasting glucagon concentrations are associated with longitudinal decline of β-cell function in non-diabetic humans.

  2020cites this paper
• HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion

  2020cites this paper
• Chapter 3 A prospective study on glucagon responses to oral glucose and mixed meal and 7-year change of fasting glucose

  2019cites this paper
• Kisspeptin and Glucose Homeostasis

  2019cites this paper
• The Multiple Facets of Kisspeptin Activity in Biological Systems

  2019cites this paper
• Health benefits of resveratrol: Evidence from clinical studies

  2019cites this paper
• A prospective study on glucagon responses to oral glucose and mixed meal and 7‐year change in fasting glucose

  2019cites this paper
• Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity‐related type 2 diabetes mellitus

  2019cites this paper
• High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine

  2018cites this paper
• Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans

  2018cites this paper
• Patterns of Plasma Glucagon Dynamics Do Not Match Metabolic Phenotypes in Young Women

  2018influential citation
• The Emerging Role(s) for Kisspeptin in Metabolism in Mammals

  2018influential citation
• The role of glucagon in weight loss‐mediated metabolic improvement: a systematic review and meta‐analysis

  2018cites this paper
• Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance

  2018cites this paper
• Effect of Frey's procedure on islet cell function in patients with chronic calcific pancreatitis.

  2018cites this paper
• Metabolic effects of glucagon in humans

  2018cites this paper
• Postprandial Insulin and Glucagon Secretions during a Mixed-Meal Tolerance Test in Dietary Induced Metabolic Syndrome Cynomolgus Monkeys

  2018cites this paper
• Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients

  2017cites this paper
• Glycemic and Metabolic Effects of Two Long Bouts of Moderate-Intensity Exercise in Men with Normal Glucose Tolerance or Type 2 Diabetes

  2017cites this paper
• A mathematical model of the impact of insulin secretion dynamics on selective hepatic insulin resistance

  2017cites this paper
• Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis

  2017cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1293 Childhood Obesity and Islet Function

  2017cites this paper
• Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.

  2016cites this paper
• Cellular Immunological Mechanisms Contributing to Diabetes Pathogenesis

  2016cites this paper
• The biology of glucagon and the consequences of hyperglucagonemia.

  2016cites this paper
• Investigating the relative contribution of obesity and glucose in the development of β-cell dysfunction

  2016cites this paper
• The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial.

  2015cites this paper
• Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus

  2015cites this paper
• Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture

  2015cites this paper
• Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block

  2015cites this paper
• Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients.

  2015cites this paper
• Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia

  2014cites this paper
• Approaching pre-diabetes.

  2014cites this paper
• Risk of postprandial insulin resistance: The liver/vagus rapport

  2014cites this paper
• Incretins: Their physiology and application in the treatment of diabetes mellitus

  2014cites this paper
• Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes

  2014influential citation
• Postprandial lipemia induces pancreatic α cell dysfunction characteristic of type 2 diabetes: studies in healthy subjects, mouse pancreatic islets, and cultured pancreatic α cells.

  2014cites this paper
• Insulino-résistance et vieillissement cardiovasculaire : un traitement chronique par le resvératrol peut-il les améliorer ?

  2013cites this paper
• A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet‐induced obese rats

  2011cites this paper
• The role of dysregulated glucagon secretion in type 2 diabetes

  2011cites this paper
• Molecular Mechanism Underlying the Intra-Islet Regulation of Glucagon Secretion

  2011cites this paper
• Diabetes - Damages and Treatments

  2011cites this paper
• Type 2 Diabetes Mellitus: Epidemiology, Genetics, Pathogenesis, and Clinical Manifestations

  2010cites this paper
• Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.

  2010influential citation
• The role of glucagon in the pathogenesis of type 2 diabetes

  2010cites this paper
• The efficacy of continuous glucose monitoring systems in the management of blood glucose levels in Type 1 Diabetes mellitus

  2010cites this paper
• Fast-to-fed shift in glucose homeostasis: clues to an earlier detection of human prediabetic states

  2010cites this paper
• Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction.

  2010cites this paper
• Insulin modulation of glucagon secretion: The role of insulin and other factors in the regulation of glucagon secretion

  2009cites this paper
• Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors.

  2009cites this paper
• β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance

  2009cites this paper
• Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus.

  2009cites this paper
• Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women.

  2009cites this paper
• Patients with Type 2 Diabetes Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in

  2009cites this paper
• Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

  2009cites this paper
• Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.

  2009cites this paper
• Emerging concepts in the pathophysiology of type 2 diabetes mellitus.

  2009cites this paper
• Do free fatty acids induce insulin resistance in alpha cells

  2009cites this paper
• K(ATP)-channels and glucose-regulated glucagon secretion.

  2008cites this paper
• The entero-insular axis: implications for human metabolism

  2008cites this paper
• Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action

  2008cites this paper
• Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.

  2008cites this paper
• Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

  2008cites this paper
• Weight Loss Therapy Improves Pancreatic Endocrine Function in Obese Older Adults

  2008cites this paper
• Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1

  2008cites this paper
• Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study

  2008cites this paper
• Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.

  2007cites this paper
• Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.

  2007cites this paper
• Vildagliptin (LAF 237): A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes Mellitus

  2006cites this paper
• Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.

  2006cites this paper
• Interplay between hormones, nutrients and adipose depots in the regulation of insulin sensitivity : an experimental study in rat and human adipocytes

  2006cites this paper
• Incretin Mimetics and Dipeptidyl Peptidase‐IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus

  2006cites this paper
• Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function

  2006cites this paper
• Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus

  2006cites this paper
• Glucagon secretion in relation to insulin sensitivity in healthy subjects

  2005cites this paper
• Lack of suppression of plasma glucagon levels in late pregnancy persists postpartum only in women with previous gestational diabetes mellitus

  2005cites this paper
• Alpha cell function in health and disease: influence of glucagon-like peptide-1

  2005cites this paper
• Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

  2005cites this paper
• Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.

  2003cites this paper
• Glucagon and regulation of glucose metabolism.

  2003influential citation
• The E 23 K Variant of Kir 6 . 2 Associates With Impaired Post – OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes

  2003cites this paper
• The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes.

  2003cites this paper
• Improved beta-cell function after standardized weight reduction in severely obese subjects.

  2003cites this paper
• The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia.

  2002influential citation